Yuki Haga

1.0k total citations
48 papers, 586 citations indexed

About

Yuki Haga is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Yuki Haga has authored 48 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hepatology, 29 papers in Epidemiology and 9 papers in Infectious Diseases. Recurrent topics in Yuki Haga's work include Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (22 papers) and Hepatitis B Virus Studies (15 papers). Yuki Haga is often cited by papers focused on Liver Disease Diagnosis and Treatment (22 papers), Hepatitis C virus research (22 papers) and Hepatitis B Virus Studies (15 papers). Yuki Haga collaborates with scholars based in Japan, United States and Spain. Yuki Haga's co-authors include Tatsuo Kanda, Masato Nakamura, Osamu Yokosuka, Shingo Nakamoto, Reina Sasaki, Shuang Wu, Xia Jiang, Koji Takahashi, Shin Yasui and Hiroshi Shirasawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yuki Haga

42 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Haga Japan 14 326 284 119 86 78 48 586
Zhenzhen Zhang China 13 387 1.2× 301 1.1× 225 1.9× 87 1.0× 77 1.0× 45 761
Wenting Tan China 15 265 0.8× 232 0.8× 99 0.8× 82 1.0× 31 0.4× 41 555
Guozhong Gong China 8 381 1.2× 405 1.4× 170 1.4× 51 0.6× 46 0.6× 18 670
Yuta Wakui Japan 13 276 0.8× 199 0.7× 88 0.7× 41 0.5× 33 0.4× 23 467
Pierre Lévy France 9 237 0.7× 113 0.4× 137 1.2× 64 0.7× 50 0.6× 12 488
Lydia L. Barlow United States 8 311 1.0× 284 1.0× 78 0.7× 43 0.5× 31 0.4× 10 486
Jin Ye China 8 283 0.9× 297 1.0× 122 1.0× 37 0.4× 34 0.4× 18 575
Guiwen Guan China 12 160 0.5× 123 0.4× 146 1.2× 138 1.6× 56 0.7× 28 453
Pamela Valva Argentina 12 250 0.8× 225 0.8× 74 0.6× 33 0.4× 25 0.3× 24 399

Countries citing papers authored by Yuki Haga

Since Specialization
Citations

This map shows the geographic impact of Yuki Haga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Haga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Haga more than expected).

Fields of papers citing papers by Yuki Haga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Haga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Haga. The network helps show where Yuki Haga may publish in the future.

Co-authorship network of co-authors of Yuki Haga

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Haga. A scholar is included among the top collaborators of Yuki Haga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Haga. Yuki Haga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haga, Yuki, Mousumi Khatun, Robert Steele, et al.. (2024). Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling. Journal of Biological Chemistry. 300(5). 107247–107247. 6 indexed citations
2.
Haga, Yuki, et al.. (2024). Hepatitis C virus chronicity and oncogenic potential: Vaccine development progress. Molecular Aspects of Medicine. 99. 101305–101305. 3 indexed citations
3.
Patra, Tapas, Keith Meyer, Yuki Haga, et al.. (2023). Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity. npj Vaccines. 8(1). 42–42. 23 indexed citations
4.
Haga, Yuki, Keith Meyer, Molly M. H. Sung, et al.. (2023). Hepatitis C virus modified sE2 F442NYT as an antigen in candidate vaccine facilitates human immune cell activation. Journal of Virology. 98(1). e0180923–e0180923. 4 indexed citations
5.
Sakai, Miho, Yuki Haga, Koji Nishimura, et al.. (2021). A case of immune-related adverse effect diffuse gastritis induced by nivolumab. Progress of Digestive Endoscopy. 98(1). 91–92.
6.
Kanda, Tatsuo, Masahiro Ogawa, Shingo Nakamoto, et al.. (2019). Superinfection of hepatitis A virus in hepatocytes infected with hepatitis B virus. International Journal of Medical Sciences. 16(10). 1366–1370. 10 indexed citations
7.
Jiang, Xia, Tatsuo Kanda, Yuki Haga, et al.. (2017). Glucose-regulated protein 78 is an antiviral against hepatitis A virus replication. Experimental and Therapeutic Medicine. 13(6). 3305–3308. 17 indexed citations
10.
Kanda, Tatsuo, Masato Nakamura, Shin Yasui, et al.. (2017). Treatment of Real-World HCV Genotype 2-Infected Japanese Patients with Sofosbuvir plus Ribavirin. Biology. 6(2). 30–30. 12 indexed citations
11.
Sasaki, Reina, Tatsuo Kanda, Masato Nakamura, et al.. (2016). Possible Involvement of Hepatitis B Virus Infection of Hepatocytes in the Attenuation of Apoptosis in Hepatic Stellate Cells. PLoS ONE. 11(1). e0146314–e0146314. 16 indexed citations
12.
Ohta, Yuki, Tatsuo Kanda, Tatsuro Katsuno, et al.. (2016). Successful sofosbuvir treatment with ribavirin dose reduction for chronic hepatitis C virus genotype 2 infection in a patient with ulcerative colitis: a case report. BMC Gastroenterology. 16(1). 66–66. 9 indexed citations
13.
Sasaki, Reina, Tatsuo Kanda, Masayuki Ohtsuka, et al.. (2016). Successful Management of Graft Reinfection of HCV Genotype 2 in Living Donor Liver Transplantation from a Hepatitis B Core Antibody-Positive Donor with Sofosbuvir and Ribavirin. Case Reports in Gastroenterology. 10(2). 366–372. 5 indexed citations
14.
15.
Sasaki, Reina, Tatsuo Kanda, Shin Yasui, et al.. (2016). Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney Transplantation. Case Reports in Gastroenterology. 10(2). 248–256. 2 indexed citations
16.
Nakamoto, Shingo, Fumio Imazeki, Makoto Arai, et al.. (2015). Effect of Hepatitis C Virus Genotype 1b Core and NS5A Mutations on Response to Peginterferon Plus Ribavirin Combination Therapy. International Journal of Molecular Sciences. 16(9). 21177–21190.
17.
Jiang, Xia, Tatsuo Kanda, Shuang Wu, et al.. (2015). Hepatitis C Virus Nonstructural Protein 5A Inhibits MG132-Induced Apoptosis of Hepatocytes in Line with NF-κB-Nuclear Translocation. PLoS ONE. 10(7). e0131973–e0131973. 4 indexed citations
18.
Sasaki, Reina, Tatsuo Kanda, Shuang Wu, et al.. (2015). Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver. Biochemical and Biophysical Research Communications. 464(4). 1192–1195. 10 indexed citations
19.
Haga, Yuki, et al.. (2012). A case report of colonic lipoma with hematochezia. Progress of Digestive Endoscopy. 80(2). 136–137.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026